Evidence map›Paper›PMID 40192333›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

The Encapsulation Strategies for Targeted Delivery of Probiotics in Preventing and Treating Colorectal Cancer: A Review.

Hao Zhong, Jin Jiang, Muhammad Hussain, Haoxuan Zhang, Ling Chen, Rongfa Guan

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Double-layer microencapsulation ofBiotechnology reports (Amsterdam, Netherlands) · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Probiotic Supplementation WithFood science & nutrition · 2026
    Article
  18. Review
  19. Review
  20. Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hao ZhongCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.ORCID https://orcid.org/0009-0005-9206-3715
Jin JiangCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.
Muhammad HussainCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.
Haoxuan ZhangCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.
Ling ChenSanya Branch of Hainan Academy of Inspection and Testing, San Ya, 572011, China.
Rongfa GuanCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.

Funding

Key Laboratory of Tropical Fruits and Vegetables Quality and Safety, State Administration for Market Regulation KF-2024003National Natural Science Foundation of China 32172202National Natural Science Foundation of China 32 402 088"Pioneer" and "Leading Goose" R&D Program of Zhejiang 2024C04012Zhejiang University of Technology- Company Crosswise Project KYY-HX-20230084Zhejiang University of Technology- Company Crosswise Project KYY-HX-20240810
6 · The paper itself

Abstract

Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide. It is associated with imbalanced gut microbiota. Probiotics can help restore this balance, potentially reducing the risk of CRC. However, the hostile environment and constant changes in the gastrointestinal tract pose significant challenges to the efficient delivery of probiotics to the colon. Traditional delivery methods are often insufficient due to their low viability and lack of targeting. To address these challenges, researchers are increasingly focusing on innovative encapsulation technologies. One such approach is single-cell encapsulation, which involves applying nanocoatings to individual probiotic cells. This technique can improve their resistance to the harsh gastrointestinal environment, enhance mucosal adhesion, and facilitate targeted release, thereby increasing the effectiveness of probiotic delivery. This article reviews the latest developments in probiotic encapsulation methods for targeted CRC treatment, emphasizing the potential benefits of emerging single-cell encapsulation techniques. It also analyzes and compares the advantages and disadvantages of current encapsulation technologies. Furthermore, it elucidates the underlying mechanisms through which probiotics can prevent and treat CRC, evaluates the efficacy and safety of probiotics in CRC treatment and adjuvant therapy, and discusses future directions and potential challenges in the targeted delivery of probiotics for CRC treatment and prevention.

Indexed as

Colorectal NeoplasmsDrug Delivery SystemsProbioticsAnimalsGastrointestinal MicrobiomeHumanscolorectal cancernanoencapsulationprobioticsprotective mechanismtargeted delivery systems

Identifiers

PMID40192333
PMCPMC12079478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.